Lehnert S, Fisher G, Methot G
Int J Radiat Biol Relat Stud Phys Chem Med. 1981 Jul;40(1):63-73.
The protective effect of pre-irradiation injections of diethylaminoreserpine (DL-152) for normal and malignant tissues in the mouse has been investigated. Dose modifying factors (DMFs) obtained for normal tissue ranged from 1.0 for bone marrow CFUs to more than 1.8 for skin. The DMFs for two transplantable tumours investigated were 1.0 for the EMT6 adenocarcinoma and 1.70 for the KHT fibrosarcoma (at a surviving fraction of 0.1. Acutely hypoxic KHT tumours were protected to a slightly lesser extent than were aerated tumours. For the KHT tumour, the number of clonogenic cells recovered from non-irradiated tumours one hour after DL-152 injection was reduced to 60 per cent of the number covered fro saline-injected controls, while, if DL-152 injected mice were acutely hypoxic at the time of sacrifice, the number of clonogenic cells was further reduced. The survival of non-irradiated EMT6 tumour cells was unaffected by DL-152 injection prior to sacrifice.
已对预先注射二乙氨基利血平(DL - 152)对小鼠正常组织和恶性组织的保护作用进行了研究。正常组织的剂量修正因子(DMF)范围从骨髓集落形成单位(CFU)的1.0到皮肤的超过1.8。所研究的两种可移植肿瘤的DMF,EMT6腺癌为1.0,KHT纤维肉瘤为1.70(存活分数为0.1时)。急性缺氧的KHT肿瘤受到的保护程度略低于通气良好的肿瘤。对于KHT肿瘤,注射DL - 152一小时后,从未受照射肿瘤中回收的克隆细胞数量减少至注射生理盐水对照组的60%,而如果在处死时注射DL - 152的小鼠处于急性缺氧状态,克隆细胞数量会进一步减少。处死前预先注射DL - 152对未受照射的EMT6肿瘤细胞的存活没有影响。